|
Volumn 28, Issue 5, 2009, Pages 576-586
|
Novel pirinixic acids as PPARα preferential dual PPARα/ γ agonists
|
Author keywords
Chirality; Drug design; Medicinal chemistry; Molecular modeling; PPAR; Structure activity relationships
|
Indexed keywords
CHIRALITY;
CYTOLOGY;
ORGANIC ACIDS;
SCAFFOLDS;
STEREOCHEMISTRY;
ALKYL SUBSTITUTION;
DOCKING STUDIES;
DRUG DESIGN;
LIGAND BINDING;
MEDICINAL CHEMISTRY;
NANOMOLAR;
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR;
RECEPTOR ACTIVITY;
STRUCTURE-ACTIVITY RELATIONSHIPS;
SUBSTITUTION PATTERNS;
ENANTIOMERS;
2 [4 (BIPHENYL 4 YLAMINO) 6 CHLOROPYRIMIDIN 2 YLTHIO]OCTANOIC ACID;
2 [4 (BIPHENYL 4 YLMETHYLAMINO) 6 CHLOROPYRIMIDIN 2 YLTHIO]OCTANOIC ACID;
2 [4 CHLORO 6 (2 PHENOXYETHYLAMINO)PYRIMIDIN 2 YLTHIO]ACETIC ACID;
2 [4 CHLORO 6 (2 PHENOXYETHYLAMINO)PYRIMIDIN 2 YLTHIO]OCTANOIC ACID;
2 [4 CHLORO 6 (4' CYANOBIPHENYL 4 YLAMINO)PYRIMIDIN 2 YLTHIO]OCTANOIC ACID;
2 [4 CHLORO 6 (5 METHOXY 2 METHYLBIPHENYL 4 YLAMINO) PYRIMIDIN 2 YLTHIO]OCTANOIC ACID;
2 [4 CHLORO 6 (PHENETHYLAMINO)PYRIMIDIN 2 YLTHIO]ACETIC ACID;
2 [4 CHLORO 6 (PHENETHYLAMINO)PYRIMIDIN 2 YLTHIO]OCTANOIC ACID;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;
PIOGLITAZONE;
PIRINIXIC ACID;
PIRINIXIC ACID DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
CELL STRAIN COS7;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG RECEPTOR BINDING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENANTIOMER;
ENANTIOSELECTIVITY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
IN VITRO STUDY;
LIGAND BINDING;
MOLECULAR DOCKING;
NONHUMAN;
PRIORITY JOURNAL;
QUANTITATIVE STRUCTURE ACTIVITY RELATION;
RECEPTOR UPREGULATION;
STEREOCHEMISTRY;
|
EID: 67649222525
PISSN: 1611020X
EISSN: 16110218
Source Type: Journal
DOI: 10.1002/qsar.200860163 Document Type: Article |
Times cited : (11)
|
References (20)
|